Navigation Links
Pancreatic Cells Turned Into Insulin-Producing Beta Cells
Date:8/27/2008

Researchers say feat could lead to treatment for diabetes

WEDNESDAY, Aug. 27 (HealthDay News) -- Scientists have succeeded in transforming pancreatic cells from adult mice into insulin-producing beta cells, a feat they call an "extreme makeover."

The achievement is a step toward finding a treatment or even a cure for both type 1 and type 2 diabetes, both of which involve problems with either insulin production or uptake.

The process, reported online Aug. 27 in Nature, bypassed some of the steps usually required in this type of procedure.

"The presently accepted regenerative medicine idea is that you make a stem cell from a patient, bring it back to the beginning as it were, then you are left with the problem of how to instruct that cell to become a beta cell or a motor neuron," explained study author Douglas Melton, co-director of the Harvard Stem Cell Institute, at a Tuesday teleconference. "We asked the simple question, why should you have to go all the way back to the beginning? Could you go from one cell type to another?"

"Up to this time, we hadn't demonstrated that you could do direct reprogramming," added Melton, who admitted to being "obsessed" with finding a cure for type 1 diabetes.

Here, Melton and his colleagues converted exocrine cells of the pancreas into neighboring endocrine cells. The process involved injecting three transcription factors -- genes which encode proteins that turn on and off other sets of genes -- into the pancreases of adult mice.

The process was surprisingly efficient, with some 20 percent of cells that received the three genes converting into beta cells.

Although these cells did ease hyperglycemia in diabetic mice, they did not respond to glucose, meaning there is still a way to go before finding a treatment or cure for the disorder.

Next, scientists are faced with the not insubstantial task of taking human cells, reprogramming them into beta cells, then coalescing them into islets or groups of beta cells to transplant into patients.

Currently, some diabetics are treated with islets taken from human cadavers, but it takes two cadavers to provide enough cells for one patient. Another option would be to convert liver cells into beta cells.

"One present treatment for some diabetics is to transplant islets into the liver, so we know that liver cells are a reasonable home for beta cells," Melton said. "If we're lucky, in two to five years, we can think about doing that in people."

It's unclear at this point, however, if three genes will be enough to accomplish this feat, given that liver cells are more distantly related to beta cells than are exocrine cells.

Researchers are reluctant to inject directly into the pancreas, a "touchy" organ, Melton said. "If we physically inject something into the pancreas, it almost always induces pancreatitis," he said. "You could be causing more trouble than what you started with."

Melton stressed that it is still imperative to continue research into highly controversial embryonic stem cells as well as induced pluripotent stem cells.

"Maybe when the history of the whole subject is written, it will be possible to say which was the best idea," he said. "I can't emphasize enough at this point that we're too ignorant to know what is the best way to treat patients and, until we know that, it is essential that we use embryonic stem cells and iPS cells to teach us about the mechanisms of disease. Until we know how to succeed, we have to aggressively pursue all avenues."

It is hoped that whatever avenue finally succeeds will be able to generate treatments or cures for a variety of diseases, including neurodegenerative diseases and cardiovascular disease.

More information

The National Institutes of Health has more on stem cells.



SOURCES: Aug. 26, 2008, teleconference with Douglas Melton, co-director, Harvard Stem Cell Institute, Cambridge, Mass.; Aug. 27, 2008, Nature, online


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cancer stem cell subpopulation drives metastasis of human pancreatic cancer
2. Chemotherapy with gemcitabine delays progression of operable pancreatic cancer
3. Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer
4. Protein Gives Clues to Pancreatic Cancer
5. The most important candidate genes for pancreatic stone formation
6. Jefferson scientists find protein helps pancreatic cancer cells evade immune system and spread
7. Elusive pancreatic progenitor cells found in mice
8. Pancreatic cancer: The smaller the tumor, the better your chances, study shows
9. Treatment Combo for Pancreatic Cancer Has Limited Benefit
10. Patrick Swayzes Diagnosis With Pancreatic Cancer: a Statement From the Pancreatic Cancer Action Network
11. Karmanos Researchers Report Enhanced Chemosensitivity of Pancreatic Cancer Cells by Black Seed Component
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pancreatic Cells Turned Into Insulin-Producing Beta Cells
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... June 23, 2016 , , ... July 7, 2016 , , , , LOCATION: , , ... , , , EXPERT PANELISTS:  , , , Frost & ... Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, ... The global pharmaceutical industry is witnessing an exceptional era. Several new ...
Breaking Medicine Technology: